Literature DB >> 9540272

Towards development of T-cell vaccines.

C A Bona1, S Casares, T D Brumeanu.   

Abstract

Recent studies on the recognition of antigens by CD4+ and CD8+ T cells have revealed new ways of preparing efficient T-cell vaccines. Here, Constantin Bona and colleagues discuss several approaches for the development of T-cell vaccines, with applications ranging from the induction of protective immunity against intracellular parasites to the development of therapeutic agents against autoimmune disorders, allergic diseases and cancer.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9540272     DOI： 10.1016/s0167-5699(97)01218-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  7 in total

1.  Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.

Authors:  G Dadaglio; Z Moukrim; R Lo-Man; V Sheshko; P Sebo; C Leclerc
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo.

Authors:  Yu-Zhang Wu; Jian-Ping Zhao; Ying Wan; Zheng-Cai Jia; Wei Zhou; Jiang Bian; Bing Ni; Li-Yun Zou; Yan Tang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Authors:  K Manoutcharian; L I Terrazas; G Gevorkian; G Acero; P Petrossian; M Rodriguez; T Govezensky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma.

Authors:  Wei Chen; Mei-Ying Cai; Da-Peng Wei; Xia Wang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

5.  On the emerging role of chemistry in the fashioning of biologics: synthesis of a bidomainal fucosyl GM1-based vaccine for the treatment of small cell lung cancer.

Authors:  Pavel Nagorny; Woo Han Kim; Qian Wan; Dongjoo Lee; Samuel J Danishefsky
Journal:  J Org Chem       Date:  2009-08-07       Impact factor: 4.354

6.  Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.

Authors:  R F Wang; X Wang; S A Rosenberg
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

7.  Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice.

Authors:  Atefeh Razazan; Jessica Nicastro; Roderick Slavcev; Nastaran Barati; Atefeh Arab; Fatemeh Mosaffa; Mahmoud Reza Jaafari; Javad Behravan
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.